Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Spoonful of technology: April-June 2025
Explore the latest technology that is changing the pharma industry, and discover how these innovations could solve key health challenges.
Read more
New investor network targets women’s health gap
WHAM’s Innovator’s Circle unites top funds to address the women’s health investment gap.
Trump’s drug pricing order hits pharma stocks
Trump’s “most-favoured nation” drug pricing plan shakes pharma markets, sparking losses for US and EU firms.
New air cargo project links medicine and agriculture
The initiative is set to revolutionise healthcare delivery and agricultural exports in low- and middle-income countries.
BMS names Cari Gallman as new General Counsel
Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 years.
Spotlight: April 2025
From new scientific data-sharing initiatives to US drug tariffs, May brought a range of major news to the pharma landscape.
Lilly partners with Alchemab for ALS candidate
Eli Lilly joins forces with Alchemab in a deal worth $415m, expanding its neuroscience pipeline with a novel candidate.
US unveils new universal vaccine platform
Generation Gold Standard is a universal vaccine platform targeting influenza, coronaviruses and future pandemics.
Novartis acquires Regulus Therapeutics and potential first-in-class therapeutic
Novartis announces acquisition of Regulus Therapeutics, adding a potential first-in-class miR-17 inhibitor to its renal pipeline.
Loading posts...
« Previous
1
2
3
4
5
6
…
30
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View